Pfizer Case Study: Protecting Blockbuster Drugs from Generic Competition
Tallennettuna:
| Aineistotyyppi: | Elektroninen E-kirja |
|---|---|
| Julkaistu: |
Marketline
2005
|
| Linkit: | Available in Business Source Ultimate. Näytä asiakasliittymässä |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|
Samankaltaisia teoksia: Pfizer Case Study: Protecting Blockbuster Drugs from Generic Competition
- Bristol-Myers Squibb Case Study: Overcoming the threat from generic Antidiabetics
- Aliskirin Case Study: Will Aliskiren Live Up to the Hype & Achieve Blockbuster Status?
- Pfizer's Maraviroc Case Study: Maraviroc is Close to Approval, Despite Hurdles Along the Way
- Prevnar: the First Vaccine Blockbuster
- Amgen Case Study: Protecting Epogen from Competition
- Black Book - Pfizer Incorporated (1973)